← Latest briefing

Science

Early-life sugar intake linked to cancer risk and biological aging, study finds

Analysis of post-war UK rationing data indicates restricting sugar during the first 1,000 days of life correlates with lower adult cancer rates decades later.

The short version

  • A study in the Proceedings of the National Academy of Sciences analyzed over 64,000 UK Biobank participants born between 1951 and 1956 to study the impact of post-war sugar rationing.
  • Researchers found that individuals exposed to sugar restrictions during their first 1,000 days of life had lower rates of adult cancers and markers of slower biological aging up to 50 years later.
  • External medical experts noted limitations including potential historical data biases, small sample sizes for individual cancers, and unmeasured post-war variables.
  • Study authors advised parents to follow standard dietary guidelines limiting added sugars rather than attempting to eliminate sugar entirely.

Key facts

  • A study published in the Proceedings of the National Academy of Sciences evaluated data from more than 64,000 UK Biobank participants born between 1951 and 1956.[Fox News]
  • The research leveraged the September 1953 end of British sugar rationing, after which daily average sugar consumption nearly doubled from 41 grams to 80 grams.[Fox News]
  • Participants with lower early-life sugar exposure exhibited lower rates of adult liver, rectal, lung, prostate, and breast cancers, as well as longer leukocyte telomeres.[Fox News]
  • Adults who spent their first 1,000 days under rationing were found to maintain healthier diets with less sugar intake five decades later.[Fox News]

What remains uncertain

  • Because the study was an observational natural experiment rather than a randomized trial, researchers could not rule out all non-sugar post-war factors or fully separate biological imprinting from lifelong eating habits.[Fox News]
  • Outside oncologists cautioned that the UK Biobank dataset has historical data biases and low case counts for specific cancers, making high percentage risk reductions potentially overambitious.[Fox News]

Sources